Amneal Pharmaceuticals (AMRX) Gross Margin Growth (3y) (2020 - 2026)
Amneal Pharmaceuticals (AMRX) Gross Margin Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 567.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -100.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 59.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -196.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -228.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 12.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -61.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Amneal Pharmaceuticals | 5.70 Bn | 5.57 Bn | 334.51 Mn | 528.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 528.00 |
| Mar 31, 2026 | 1,235.00 |
| Dec 31, 2025 | 5,010.00 |
| Sep 30, 2025 | -68.00 |
| Jun 30, 2025 | 366.00 |
| Mar 31, 2025 | 172.00 |
| Dec 31, 2024 | 499.00 |
| Sep 30, 2024 | 82.00 |
| Jun 30, 2024 | -410.00 |
| Mar 31, 2024 | -273.00 |
| Dec 31, 2023 | 4,503.00 |
| Sep 30, 2023 | 1,178.00 |
| Jun 30, 2023 | 569.00 |
| Mar 31, 2023 | -485.00 |
| Dec 31, 2022 | -4,135.00 |
| Sep 30, 2022 | 2,121.00 |
| Jun 30, 2022 | 984.00 |
| Mar 31, 2022 | 1,646.00 |
| Dec 31, 2021 | -788.00 |
| Sep 30, 2021 | -444.00 |